Pharma Veterans

Healthcare Landscape in Pakistan – Sum Up – Asrar Qureshi’s Blog Post #987 Dear Colleagues! This is Asrar Qureshi’s Blog Post #987 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to aq.pharmaveterans@gmail.com for publishing your contributions here. Credit: Ahmet Kurt Credit: Anna Shvets Credit: Tima Miroshnichenko This is the 12th blog post on the topic of healthcare in this series. I have talked about all major stakeholders, their roles, and their issues. It is time to sum up the entire discussion, hence this post. Rather than summing up all the points discussed so far, I shall talk about the impact of various stakeholders on the healthcare system in Pakistan. I shall focus on the system itself under various heads. Strengths Pakistan can rightly claim to have a highly developed, elaborate healthcare system among low-and-middle-income countries (LMICs). There are separate, dedicated institutes for...

Corporate Management in Larger Organizations – Asrar Qureshi’s Blog Post #940 Dear Colleagues! This is Asrar Qureshi’s Blog Post #940 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to aq.pharmaveterans@gmail.com for publishing your contributions here. Credit: Anete Lusina Credit: Brett Sayles Credit: Markus Winkler In this blog post, I shall present findings about corporate management or governance in larger organizations, be they private or public. Corporate management is the system of rules, practices, and processes through which a company is run, controlled, and directed. The culture of the organization evolves from governance, not the other way round. Corporate management, as mentioned earlier also, must balance the interests of all stakeholders. The shareholders should get return on their investment, suppliers look for on time payment of supplies, employees look for safe environment and caree...

Policies - Compliance - Culture – Asrar Qureshi’s Blog Post #839 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #839 for Pharma Veterans. Pharma Veterans aims to share knowledge and wisdom from Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on  WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Elizabeth Holmes - CEO Theranos Pfizer gabapentin Pharmaceutical industry is regarded as a highly regulated industry and rightly so. At every step, regulations are applied. The data generated during production and quality control is religiously documented and vetted at various levels. Research data is subjected to even more rigorous vetting. When the local or international teams visit for inspection, their main emphasis is on reviewing documents. The process is simple; they ask for SOPs, review these, and then ask for compliance reports. Compliance becomes the key parameter...

Challenges for Pakistan Pharma Industry in 2023 – Part 3 – Asrar Qureshi’s Blog Post #773 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #772 for Pharma Veterans. Pharma Veterans welcome sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on  WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Photo Credit: Alena Darmel Photo Credit: Anete Lusina Photo Credit: Tima Miroshnichenko Cost of Compliance Pharma industry is a highly regulated industry and regulations are applied at every step. The changes have occurred mostly in the last four decades, and we have witnessed it first hand. Compliance has increased both ways; new regulations have been put in place, and more stringent compliance is required. This has added to the cost of doing production. Compliance starts from raw materials and goes through production, storage, distribution and ...

Pakistan Pharma Industry SWOT – Part 24 – Asrar Qureshi’s Blog Post #615 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #615 for Pharma Veterans. Pharma Veterans welcome sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Opening Note February 2022 marked my completing 47 years of working in Pharma Industry. Allah be praised. I am still working. The first half of my working career was spent in Multinational companies, and the latter half in the Local Pharma, making me well-versed with both innovators and generics markets. I also had the opportunity to work in business as well as operations.  My journey of near half century is also the journey of Pharma Industry in Pakistan. Great changes have occurred in this time and a lot could be written about it. In my blogs, which were started...

Corruption in Pharmaceuticals – International Perspective 4 – Blog Post #497 by Asrar Qureshi Dear Colleagues!  This is Pharma Veterans Blog Post #497. Pharma Veterans welcomes sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Continued from Previous…… This series is based on a report compiled by Jilian Clare Cohen1, Monique Mrazek2, and Loraine Hawkins3 for World Bank. Corruption is spread easily across many areas if the regulatory systems are inefficient and/or incompetent. Pharmaceutical business is among the most regulated businesses and is therefore subject to the same phenomena. Not long ago, Pharma was rather loosely regulated. However, there have significant changes in the last three decades or so. The regulators have identified areas where corruption may occur and have installed r...